FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Actemra (tocilizumab) filed by Genentech, Inc., resulting in an approved update to the product's labeling and/or ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis
• Polyarticular Juvenile Idiopathic Arthritis
• Rheumatoid Arthritis
• Systemic Juvenile Idiopathic Arthritis

Drugs mentioned

• Actemra (tocilizumab)

Snippet

SUPPL AP for ACTEMRA (TOCILIZUMAB)